Skip to main content
Tech.euFundingExplorerBeta

Seamless Therapeutics

Therapeutic potential of gene editing

Total raised
€12M
€11,787,449
Funding rounds
1
Investors
3
distinct backers
Active since
2023-03
latest 2023-03

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood32
base rate 44% for Seed
  • Overdue vs cohort gap
  • Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2023-03-16Seed€12MBMBF GO-Bio,Forbion,Wellington PartnersView deal →

Similar companies

same sector or country